Next Article in Journal
Fusarium spp. in Metalworking Fluid Systems: Companions Forever
Previous Article in Journal
Seroprevalence and Risk Factors for Cysticercosis in Mexican Americans in Starr County, Texas
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multidrug Resistance of Gallibacterium anatis Biovar Haemolytica Isolated from the Reproductive Tracts of Laying Hens

Department of Poultry Diseases, National Veterinary Research Institute, 24-100 Puławy, Poland
Pathogens 2024, 13(11), 989; https://doi.org/10.3390/pathogens13110989
Submission received: 18 October 2024 / Revised: 6 November 2024 / Accepted: 12 November 2024 / Published: 12 November 2024
(This article belongs to the Section Bacterial Pathogens)

Abstract

:
Antimicrobial resistance is recognized worldwide as one of the greatest threats to human and animal health and the environment. To evaluate the resistance rate of Gallibacterium anatis biovar haemolytica, which contributes to bacteremia, oophoritis, ovarian follicle degeneration, salpingitis, decreased egg production, and increased mortality in hens, strains isolated from the reproductive tracts of layers were analyzed. The oviducts were taken from three hens from each of 10 flocks manifesting clinical signs related to laying. Twenty-two isolates of G. anatis biovar haemolytica collected from the three parts of the reproductive system were identified using MALDI-TOF and molecular methods. The biovar’s resistance to 19 antimicrobial substances was assessed using the disk diffusion (n = 8) and broth microdilution (n = 11) methods. The presence of virulence (gtxA, gyrB, and flfA) and antibiotic resistance (blaROB, aphA, tetB, and tetH) genes was examined using PCR. All the isolates were resistant to four or more classes of antibiotics and were considered multidrug-resistant. All such isolates were resistant to tilmicosin, tylosin, and enrofloxacin, 88.2% were to tetracycline, and 82.4% to vancomycin. The gtxA, gyrB, tetB, and tetH genes were demonstrated. Considering the present prevalence of multidrug resistance among G. anatis biovar haemolytica isolates from laying hen reproductive tracts, surveillance in reproductive flocks is warranted.

1. Introduction

Multidrug resistance in commensal bacteria is an important problem worldwide. Multidrug resistance (MDR) in bacteria makes infections more difficult to treat, increasing treatment costs and leading to additional morbidity and mortality. This resistance is the result of evolution in commensal bacteria that encounter a variety of antibiotics prescribed to a host population treated multiple times with them [1]. In many cases, resistance is spontaneous and occurs independently of mutations or the acquisition of exogenous resistance determinants [1,2,3,4].
Gram-negative bacteria are more resistant to antimicrobials because of the presence of an outer membrane barrier to permeability. Phenotypically, the Gram-negative bacterium G. anatis has been divided into two different biovars based on their hemolytic properties: “haemolytica”, which causes β-hemolysis, and “anatis” as a non-hemolytic variant [5,6,7]. The haemolytica biovar of G. anatis has the greatest impact on poultry health, being associated with diseases of the systems in which it is found [8,9]. Under normal conditions, infection with G. anatis typically does not result in specific clinical symptoms or severe changes. However, in immunocompromised birds, G. anatis biovar haemolytica strains can enter the bloodstream, leading to septicemia and multiorgan inflammation [7,10]. The infection may extend beyond the upper respiratory tract, causing pericarditis, perihepatitis, liver necrosis, peritonitis, and enteritis [7]. In the reproductive system, it can manifest as oophoritis, hemorrhaging and rupture of ovarian follicles, follicular atresia, and salpingitis. In roosters, infections lead to reduced semen quality, lower sperm density, impaired motility, and loss of membrane integrity [7,8,11,12] Gallibacterium anatis primarily affects intensively farmed poultry and results in production losses, high mortality in broilers, and reduced egg production in laying hens. Recently, declines in egg-laying efficiency have been increasingly linked to acute or chronic salpingitis and reproductive tract inflammation caused by G. anatis [5,12,13,14,15].
These bacteria use adhesion and invasion as initial virulence mechanisms. After entering the bird’s body, they adhere to the epithelial cells of the oropharyngeal cavity or oviducts of hens [16]. During the disease process, the bacteria multiply rapidly and the synthesis of virulence factors begins [7,17,18]. Highly virulent strains of G. anatis adhere better to the primary oviduct epithelial cells of hens and trigger more intensive production of inflammatory cytokines (IL-6, TNF-α, and IFN-γ), indicating the induction of inflammation and the ability to cause damage to infected tissues [19]. Many specific virulence factors produced by G. anatis have been identified which can significantly affect the pathogenicity of a strain. These factors include the GtxA toxin; outer membrane vesicles; fimbriae; metalloproteases; biofilm; elongation factor thermo-unstable (EF-Tu) protein; clustered, regularly interspaced, short palindromic repeats (CRISPR); and integrative and conjugative elements (ICEs), whose presence significantly affects the development of the disease [5,7,17,18,19,20,21,22,23].
The most common route of transmission of this pathogen is horizontal through direct contact between infected birds. Another possibility for the spread of infection is the vertical route, through the ovary or fallopian tube or by the penetration of the pathogen through the eggshell, which significantly affects the developing embryo. In the case of infection in roosters, venereal transmission is also possible [5,7,8].
The spread of antibiotic-resistant bacteria in poultry with phenotypes extending to more than one class of antibiotics is a serious public health problem, and understanding the causes of MDR bacterial prevalence is important for reducing the incidence of resistance. Infections caused by G. anatis biovar haemolytica can lead to significant economic losses in the poultry industry. Understanding the action of this biovar in the avian reproductive system is crucial for the proper management and prevention of infections to ensure the health and productivity of poultry flocks and reduce the use of antibiotics in poultry production. In this work, we report on the multidrug resistance of G. anatis biovar haemolytica isolated from different parts of the reproductive tract of laying hens with signs of infection.

2. Materials and Methods

2.1. Sample Collection

From May 2022 to April 2024, diseased layer hens were submitted to the Department of Poultry Diseases at the National Veterinary Research Institute in Poland for routine diagnostic testing. In this study, birds were examined from 10 flocks from different parts of the country in which clinical signs associated with a decline in laying and egg quality problems had been found. After euthanizing three birds per flock by decapitation, necropsies were conducted under aseptic conditions, during which tissue and swab samples of the oviduct were collected. Reproductive tract samples comprising the ovarium, infundibulum, and uterus (as the middle sections of each part) were collected.

2.2. Isolation and Identification of Gallibacterium anatis

All oviduct samples were suspended in tris buffer (10 mM, pH 8.5; Eurx, Gdańsk, Poland) and homogenized using a manual LabGEN 125 device (Cole-Parmer, Vernon Hills, IL, USA). Every part of the homogenized tissue was transferred onto Columbia agar plates with 5% sheep’s blood and incubated at 37 °C under a 5% CO2 atmosphere for 24 h. The reference strain Gallibacterium anatis ATCC 43329 was used as a positive control. The bacterial colonies that produced β-hemolysis from the agar plate were transferred to a MALDI-TOF MS target plate and mixed with formic acid and α-cyano-4-hydroxycinnamic acid matrix solution. All mass spectra were analyzed with Bruker Daltonics v.4.1.70 software (Bruker Corporation, Billerica, MA, USA) and had index values at levels of 2.000–2.299.

2.3. Antibiotic and Multidrug Resistance

The disk diffusion and microbroth dilution methods were used to determine the antibiotic resistance of G. anatis biovar haemolytica isolates. The susceptibility of the isolates to 19 different antibiotics from 12 classes was tested. Resistance to 8 antibiotics was tested with the disk diffusion method (Oxoid, Basingstoke, UK), and resistance to 11 others was evaluated with the microbroth dilution method. The test applied a bacteria volume of 100 μL of 1.5 × 107 CFU/mL (0.5 McFarland scale) distributed uniformly onto the Columbia agar with 5% sheep’s blood. Eleven antibiotics from nine classes were used: the quinolone florfenicol (30 μg), the β-lactams doxycycline (30 μg) and amoxicillin (25 μg), the fluoroquinolone enrofloxacin (5 μg), the polymyxin colistin (50 μg), the cephalosporin ceftazidime (30 μg), and the macrolides tilmicosin (15 μg) and tylosin (30 μg). The inhibition zones were interpreted visually.
Determination of minimum inhibitory concentration (MIC) was performed according to the Clinical and Laboratory Standards Institute M31-A2 standard [24] using a commercially prepared dehydrated panel for Enterobacteriaceae (Sensititre EU Surveillance Enterococcus EUVENC AST plate; Thermo Fisher Scientific, Waltham, MA, USA). The plates were incubated for 20–24 h at 37 ± 1 °C under aerobic conditions. Antimicrobial resistance (AMR) testing of G. anatis biovar haemolytica was performed from a fresh culture on agar and a suspension prepared at 0.5 McFarland density in 0.9% NaCl (bioMérieux, Marcy-l’Étoile, France), of which 10 μL was transferred to 11 mL of Mueller–Hinton broth (Thermo Fisher Scientific). The suspension was thoroughly vortexed and then 50 μL of it was added to each well of a plate. The plates contained different concentrations of 11 antibiotics: 8–1024 mg/L preparations of the aminoglycoside gentamicin, 0.5–64 mg/L concentrations of the β-lactam ampicillin, 0.12–16 mg/L solutions of the fluoroquinolone ciprofloxacin, respective 0.5–64 mg/L and 1–128 mg/L concentrations of the glycopeptides teicoplanin and vancomycin, 0.25–32 mg/L solutions of the lipopeptide daptomycin, 1–128 mg/L concentrations of the macrolide erythromycin, 0.5–64 mg/L preparations of the oxazolidinone linezolid, 0.5–64 mg/L solutions of the streptogramin quinupristin/dalfopristin, and respective 0.03–4 mg/L and 1–128 mg/L concentrations of the tetracyclines tigecycline and tetracycline. The plates were incubated for 24 h at 37 ± 1 °C. The MIC was defined as the lowest concentration preventing growth which was visible using a plate reader (Sensititre-TREK Vizion Digital MIC Viewing System; Thermo Fisher Scientific). Strains resistant to at least three classes of antimicrobials were identified as MDR.

2.4. DNA Extraction

Identified colonies of G. anatis biovar haemolytica were suspended in tris-EDTA buffer (10 mM, pH 8.5; Eurx, Gdańsk, Poland). Genomic DNA was extracted using a Maxwell RSC Cultured Cells DNA Kit (Promega, Madison, WI, USA) according to the manufacturer’s recommendations. The quantity and quality of the DNA was determined using the NanoDrop 1000 system (Thermo Scientific, Waltham, MA, USA). Extraction of DNA from the tris-EDTA used for sample preparation was conducted as a negative control. Samples were frozen at −20 °C until future analysis.

2.5. Real-Time PCR and PCR

The isolates of G. anatis were identified by real-time PCR using primers complementary to the gyrB gene described by Wang et al. [25], with slight modifications which were reported previously [26].
The PCR was conducted using specific G. anatis primers which amplified the 16S–23S rRNA gene [27] and with the temperature and time conditions described previously [28].

2.6. Virulence and Resistance Genes

The isolated DNA was used to perform a PCR test for the detection of the gyrB, gtxA, and flfA virulence genes. All samples were also tested for the presence of antibiotic resistance genes, namely blaROB (a β-lactam resistance gene), aphA (an aminoglycoside resistance gene), and tetB and tetH (tetracycline resistance genes). The primers described earlier by Algammal et al. were used [23].

2.7. Presence of Other Bacterial Pathogens

Detection of other bacteria was undertaken in swab samples taken from the reproductive tracts of hens. The swab samples were suspended in tris-EDTA buffer. A 10 μL volume of supernatant was inoculated onto MacConkey agar, tryptic soy agar, bile esculin azide agar, and Columbia agar plates with 5% sheep’s blood (PIWet-PIB, Pulawy, Poland). The plate with MacConkey agar was incubated at 37 °C for 24 h. The plates with tryptic soy agar, bile esculin azide agar, and Columbia agar were incubated at 37 °C under a 5% CO2 atmosphere for 24 h. The obtained colonies were verified by MALDI-TOF MS.
The remainder of the suspension from the oviduct swabs was used for DNA extraction. Genomic DNA was extracted using a QIAamp DNA Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s recommendations. Samples were frozen at −20 °C until future analysis was undertaken.
The presence of DNA of Mycoplasma synoviae and M. gallisepticum was detected by PCR with primers complementary to the vlhA gene for M. synoviae [29,30] and to the mgc2 gene for M. gallisepticum [30,31]. The presence of Ornithobacterium rhinotracheale was tested in a real-time PCR targeting the 16S rRNA gene according to Abdelwhab et al. [32,33]. The PCR amplicons were separated by electrophoresis on a 2% agarose gel containing ethidium bromide and were visualized by ultraviolet transillumination.

2.8. Statistical Analysis

Statistical analysis was conducted using one-way ANOVA and the Mann–Whitney test to assess the significance of the presence of virulence genes and oviduct changes. A p-value of <0.05 was considered statistically significant. All analyses were performed using the Social Science Statistics program (www.socscistatistics.com, accessed on 13 October 2024).

3. Results

3.1. Isolation and Identification of Gallibacterium anatis Biovar Haemolytica

Post-mortem examination of laying hens most often found ovarian inflammation, degeneration of ovarian follicles, congestion or inactivity of the oviducts, or their non-functional state. Figure 1 shows the degeneration of the ovarian follicles and the reduction of the oviduct. Changes in the oviduct were found in 48.5% of the birds examined. There were birds in every flock in which at least one of the listed changes was found. Twenty-two isolates of G. anatis biovar haemolytica were obtained from the reproductive system organs of the laying hens, which were confirmed by MALDI-TOF MS. A summary of the obtained isolates’ origins is shown in Table 1. Seven isolates originated from the ovaries, fifteen from the uterus, but none from the infundibulum.

3.2. Antibiotic and Multidrug Resistance

The 22 isolates of G. anatis confirmed by MALDI-TOF MS were evaluated for antibiotic resistance. Seven isolates were obtained from the ovaries and fifteen from the uterus. Five isolates obtained from ovaries showed the same profile as isolates from the uterus and the other two showed a different profile. As a result, 17 distinct profiles were analyzed. Among the isolates, 100% were resistant to tilmicosin, tylosin, and enrofloxacin; 88.2% were to tetracycline; 82.4% to vancomycin; and 76.5% to erythromycin, linezolid, quinupristin/dalfopristin, ampicillin, amoxicillin, gentamicin, and teicoplanin. Ciprofloxacin and daptomycin were resisted by 70.6% of isolates and doxycycline by 41.2%. In contrast, 88.2% of strains were sensitive to florfenicol and ceftazidime, 70.6% were to tigecycline, and 64.7% to colistin (Figure 2).
This biovar of G. anatis as isolated from the reproductive tracts of layer hens presenting clinical cases exhibited 100% multidrug resistance. Most G. anatis biovar haemolytica isolates were resistant to 15 (41.2%) or 14 (29.4%) antibiotics belonging to 10 (29.4%) or 9 (41.2%) different classes. Among the isolates obtained, only one was resistant to 16 antibiotics (5.9%) belonging to 11 different classes. Two isolates (11.8%) showed resistance to six antibiotics from four different classes while single isolates showed resistance to nine (5.9%) and five (5.9%) antibiotics from six and three classes, respectively (Figure 2 and Figure 3).
Thirteen AMR profiles were found in the set of isolates analyzed. Unique AMR profiles were found in 10 isolates, and identical profiles were found in birds from the same flock (Table 2).

3.3. Real-Time PCR and PCR

DNA was extracted from the 22 isolates of MALDI-TOF MS–confirmed G. anatis biovar haemolytica. All samples in real-time PCR had a Ct range from 19.45 to 34.2. All isolates also showed two-band amplicons in PCR confirming the presence of Gallibacterium spp. The results of real-time PCRs and PCRs confirmed the presence of genetic material of G. anatis in all isolates.

3.4. Presence of Virulence and Resistance Genes

The gtxA and gyrB virulence genes were detected in 100% of the isolates, and the flfA virulence gene was detected in 22.7% of them. Statistically significant differences (p < 0.05) were found between the presence of virulence genes and changes in the oviducts of the hens. The tetB resistance gene was present in 100% of G. anatis biovar haemolytica isolates, while the tetH gene was found in 27.3% of them. The aphA and blaROB genes were not detected in the examined isolates.

3.5. Presence of Other Bacterial Pathogens

In cultures from the oviducts of hens where G. anatis biovar haemolytica was found, Staphylococcus hyicus, S. sciuri, S. chromogenes, S. simulans, S. aureus, Streptococcus alactolyticus, E. coli, Enterococcus cecorum, E. faecium, and Kurthia gibsonii were identified by MALDI-TOF. The presence of M. synoviae DNA was found in oviducts of five laying hens. The isolated M. synoviae strains showed the greatest similarity to the MS-H (Mycoplasma synoviae-H) vaccine strain in phylogenetic analysis, which almost certainly originated from the vaccine given to the hens. However, genetic material of O. rhinotracheale was detected in six oviducts. No presence of M. gallisepticum DNA was observed in the tested samples.

4. Discussion

Gallibacterium anatis is an important pathogen found in poultry around the world. The symptoms occurring with biovar haemolytica infection can cause significant losses in poultry production. However, the biggest problem is the increasing multidrug resistance of this pathogen, which has been described by many scientists [6,14,26,34,35,36]. Several publications have described its resistance to a number of antimicrobial substances. The task of this study was to evaluate the multidrug resistance of isolates of G. anatis biovar haemolytica obtained from the reproductive tracts of hens showing clinical signs of infection.
Infections with G. anatis biovar haemolytica in laying hens frequently result in oviduct inflammation, swelling, and the accumulation of purulent secretions and fibrin deposits, along with degeneration of ovarian follicles. This leads to a reduction in egg production ranging from 3 to 18% under natural conditions due to damage to the oviducts and an overall decline in hen health [15,16,21,35,36]. In experimentally infected birds, egg production drops by as much as 66% and 47% during the first and third weeks post infection, respectively. Cumulative flock mortality rates between 0.06 and 4.9% have also been reported [12,19]. Samples from laying hens in this study showed lesions associated with ovarian inflammation, degeneration of ovarian follicles, and oviduct congestion or inactivity. G. anatis biovar haemolytica was isolated from oviduct samples, which may suggest their influence on the development of lesions as reported by other researchers [35,37,38,39].
The antibiotic resistance results of G. anatis isolates obtained from the reproductive systems of laying hens in several other studies suggested a high level of resistance to many antimicrobial agents commonly used in both veterinary and human medicine [8,23,35,39,40]. In studies conducted in the USA and Austria, high resistance to the macrolide antibiotic tylosin (85.3–100%) and tetracycline (88.2–100%) was observed, which is consistent with the results obtained in this study [34,35,41]. In studies conducted in Poland by Karwańska et al. [39], strains isolated from laying hens showed 50% resistance, which is less than that of isolates from the USA [41], Austria [35], and this study. Resistance to tetracyclines and macrolides seems to be common in various regions of the world, suggesting the limited effectiveness of these classes of antibiotics in treating infections caused by Gallibacterium anatis.
The varying susceptibility of the studied G. anatis strains to commonly used antibiotics nevertheless suggests that some treatment options remain effective, although their efficacy is not universal. In the study by Shabbir et al. [41], G. anatis isolates were resistant to penicillin (98%) but susceptible to cephalosporins (100%). However, among Austrian isolates, resistance to oxacillin (98.1%) and partial resistance to cefazolin (21.1%), ceftazidime (20.6%), and β-lactam antibiotics (up to 29%) was observed [35]. In this study, the isolates showed high resistance to ampicillin (76.5%) and amoxicillin (76.5%), but the isolates were susceptible to ceftazidime (88.2%). However, the resistance gene blaROB and aphA were not found in the tested isolates. Among isolates obtained from western Poland in earlier research, the isolates were fully resistant to penicillin (100%) and cefotaxime (100%) but fully susceptible to the cephalosporins ceftiofur and ceftazidime (100%) [39]. In studies conducted by Algammal et al. [23], resistance to penicillin and ampicillin was 95.9%. Resistance to both antibiotics in the fluoroquinolone class was high in the isolates obtained from hens in this study (100% were resistant to enrofloxacin and 70.6% to ciprofloxacin), which is consistent with the 91.2% obtained in the studies by Karwańska et al. Ref. [39] suggests that strains with high resistance to fluoroquinolones are present in Poland. However, in the strains isolated in Austria, resistance to enrofloxacin was lower at 58.2% [35], and was non-existent in strains in the USA, 100% of which were susceptible [41]. The growing resistance to several key antimicrobial agents further limits treatment options. Multidrug-resistant isolates also showed 76.5% resistance to erythromycin, linezolid, quinupristin/dalfopristin, ampicillin, amoxicillin, gentamicin, and teicoplanin. Resistance to daptomycin was 70.6% and resistance to doxycycline was 41.2%.
The high observed MDR in this study is comparable to the results observed in chickens in other countries, and not only in isolates from the reproductive system; isolates from the USA, Austria, Egypt, Germany, and Poland were resistant to many drugs, including enrofloxacin, macrolides, tetracyclines, and penicillin [5,8,23,35,41,42]. Studies conducted by Algammal et al. showing correlations between resistance to any antimicrobial agent and resistance to other specific agents suggest that resistance to one often coincides with resistance to others, which can further complicate treatment protocols for G. anatis infections [23].
The occurrence of MDR strains, particularly in the case of commonly used antibiotics, highlights the importance of careful management of antimicrobial agents in poultry farming. The antibiotics in use are becoming ever less effective against G. anatis, and alternative treatment methods or preventive measures are needed.
The most fully characterized virulence factor of G. anatis is the GtxA toxin, the protein responsible for the hemolytic activity of G. anatis biovar haemolytica. The GtxA protein is similar to the RTX toxins of the Pasteurellaceae family in terms of sequencing and to α-hemolysin (HlyA), which is found in E. coli [20,21,43]. The binding of the GtxA toxin to the actin present in host immune cells can alter cell structure and impede cell signal transduction, and thus the bacterium can avoid the host immune system [20,21,43]. Isolates tested in this study showed β-hemolysis, and the gtxA and gyrB virulence genes were confirmed in 100% of them. In contrast, the presence of the flfA virulence gene was found to a lesser extent, in 22.7% of the isolates. The harboring by G. anatis of a number of genes related to its ability to defend itself against antibiotics, such as those encoding the EF-Tu and CRISPR proteins, renders successful elimination of it from the bird’s body a major challenge. In addition to these genes, ICEs have been found in G. anatis strains, which contain antibiotic resistance genes and have the potential to pass them on to other bacteria [5,7,18,44].
The development of the disease caused by G. anatis is influenced by many physiological and environmental factors, which can affect the duration of infection and mortality of birds in the flock. An additional complicating or initiating factor in the development of symptoms may be exposure of the flock to mixed infections associated with bacterial or viral contamination. Gallibacterium can cause primary or secondary infections leading to more severe clinical symptoms. Because strongly developed clinical symptoms were present in the studied flocks, samples were tested for the presence of other pathogens that could escalate infections. In some flocks, mixed infections were found with O. rhinotracheale, E. coli, M. synoviae, Enterococcus faecium, E. cecorum, Staphylococcus aureus, or Kurthia gibsonii. The occurrence of mixed infections has already been described in different reports [15,45,46,47,48]. Some of these bacteria are unable to cause infection when they alone are the pathogen, but rather are opportunistic pathogens which cause significant losses in poultry production in co-infections.

5. Conclusions

In conclusion, the antimicrobial resistance of G. anatis biovar haemolytica indicates serious challenges in treating infections with this pathogen in poultry because high levels, of co-resistance and multi-resistance are observed in certain strains. The widespread resistance of G. anatis to a number of commonly used antibiotics and its possession of a number of genes associated with its defense and ability to transmit resistance to other bacteria call for a more cautious use of antimicrobials and the search for alternative treatment strategies.

Funding

The study was funded by a subsidy provided by the Ministry of Science and Higher Education under the grant no. S/486 in 2022–2025 to the National Veterinary Research Institute, Pulawy, Poland.

Institutional Review Board Statement

The samples were collected from commercial layer farms by authorized veterinarians during clinical studies following standard procedures for diagnostic examination. All methods used in this study were carried out in accordance with relevant guidelines and regulations. Formal ethical approval is not required for this kind of study (Directive 2010/63/EU Chapter I, Article 1, paragraph 5, points b, d, f).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available because of legislation protecting privacy.

Acknowledgments

The author would like to thank Sylwia Kostka and Karolina Piekarska for their help with the testing of the samples.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Jacopin, E.; Lehtinen, S.; Débarre, F.; Blanquart, F. Factors Favouring the Evolution of Multidrug Resistance in Bacteria. J. R. Soc. Interface 2020, 17, 20200105. [Google Scholar] [CrossRef]
  2. George, A.M. Multidrug Resistance in Enteric and Other Gram-Negative Bacteria. FEMS Microbiol. Lett. 1996, 139, 1–10. [Google Scholar] [CrossRef] [PubMed]
  3. Lehtinen, S.; Blanquart, F.; Lipsitch, M.; Fraser, C. On the Evolutionary Ecology of Multidrug Resistance in Bacteria. PLoS Pathog. 2019, 15, e1007763. [Google Scholar] [CrossRef] [PubMed]
  4. Nikaido, H. Multidrug Resistance in Bacteria (Author Manuscript). Annu. Rev. Biochem. 2009, 78, 119–146. [Google Scholar] [CrossRef]
  5. Varan Singh, S.; Singh, B.R. Gallibacterium anatis: An Emerging Pathogen of Poultry Birds and Domiciled Birds. J. Vet. Sci. Technol. 2015, 7, 3. [Google Scholar] [CrossRef]
  6. Bojesen, A.M.; Nielsen, O.L.; Christensen, J.P.; Bisgaard, M. In Vivo Studies of Gallibacterium anatis Infection in Chickens. Avian Pathol. 2004, 33, 145–152. [Google Scholar] [CrossRef]
  7. Narasinakuppe Krishnegowda, D.; Dhama, K.; Kumar Mariappan, A.; Munuswamy, P.; Iqbal Yatoo, M.; Tiwari, R.; Karthik, K.; Bhatt, P.; Reddy, M.R. Etiology, Epidemiology, Pathology, and Advances in Diagnosis, Vaccine Development, and Treatment of Gallibacterium anatis Infection in Poultry: A Review. Vet. Q. 2020, 40, 16. [Google Scholar] [CrossRef]
  8. Paudel, S.; Alispahic, M.; Liebhart, D.; Hess, M.; Hess, C. Assessing Pathogenicity of Gallibacterium anatis in a Natural Infection Model: The Respiratory and Reproductive Tracts of Chickens Are Targets for Bacterial Colonization. Avian Pathol. 2013, 42, 527–535. [Google Scholar] [CrossRef]
  9. Schink, A.K.; Hanke, D.; Semmler, T.; Roschanski, N.; Schwarz, S. Genetic Organization of Acquired Antimicrobial Resistance Genes and Detection of Resistance-Mediating Mutations in a Gallibacterium anatis Isolate from a Calf Suffering from a Respiratory Tract Infection. Antibiotics 2023, 12, 294. [Google Scholar] [CrossRef]
  10. Paudel, S.; Liebhart, D.; Aurich, C.; Hess, M.; Hess, C. Pathogenesis of Gallibacterium anatis in a Natural Infection Model Fulfils Koch’s Postulates: 2. Epididymitis and Decreased Semen Quality Are the Predominant Effects in Specific Pathogen Free Cockerels. Avian Pathol. 2014, 43, 529–534. [Google Scholar] [CrossRef]
  11. Castillo, G.; Koga, Y.; Alvarado, A.; Tinoco, R.; Fernández, D. Isolation and Biochemical Characterization of Pasteurella Multocida and Gallibacterium anatis Strains in Poultry with Respiratory Signs. Rev. Investig. Vet. Peru 2014, 25, 516–522. [Google Scholar] [CrossRef]
  12. Elbestawy, A.R.; Abd-Ellatieff, H.A.; Ellakany, H.F.; Abd El-Hamid, H.S.; Abou Rawash, A.A.; Gado, A.R.; Abd El-Aziz, A.H.; Eid, A.A.M.; El-Shall, N.A. Respiratory and Reproductive Impairment of Commercial Layer Chickens after Experimental Infection with Gallibacterium anatis Biovar Haemolytica. Avian Dis. 2020, 64, 536–541. [Google Scholar] [CrossRef] [PubMed]
  13. Bojesen, A.M.; Torpdahl, M.; Christensen, H.; Olsen, J.E.; Bisgaard, M. Genetic Diversity of Gallibacterium anatis Isolates from Different Chicken Flocks. J. Clin. Microbiol. 2003, 41, 2737–2740. [Google Scholar] [CrossRef] [PubMed]
  14. Yaman, S.; Şahan Yapicier, O. Diagnosis of Gallibacterium anatis in Layers: First Report in Turkey. Rev. Bras. Cienc. Avic. 2019, 21, eRBCA-2019. [Google Scholar] [CrossRef]
  15. Neubauer, C.; De Souza-Pilz, M.; Bojesen, A.M.; Bisgaard, M.; Hess, M. Tissue Distribution of Haemolytic Gallibacterium anatis Isolates in Laying Birds with Reproductive Disorders. Avian Pathol. 2009, 38, 1–7. [Google Scholar] [CrossRef]
  16. Zhang, X.P.; Lu, C.J.; Li, Y.T.; Yang, X.; Wang, X.W.; Chang, H.T.; Liu, H.Y.; Chen, L.; Zhao, J.; Wang, C.Q.; et al. In Vitro Adherence and Invasion of Primary Chicken Oviduct Epithelial Cells by Gallibacterium anatis. Vet. Microbiol. 2017, 203, 136–142. [Google Scholar] [CrossRef]
  17. Bager, R.J.; Nesta, B.; Pors, S.E.; Soriani, M.; Serino, L.; Boyce, J.D.; Adler, B.; Bojesen, A.M. The Fimbrial Protein FlfA from Gallibacterium anatis Is a Virulence Factor and Vaccine Candidate. Infect. Immun. 2013, 81, 1964–1973. [Google Scholar] [CrossRef]
  18. Persson, G.; Bojesen, A.M. Bacterial Determinants of Importance in the Virulence of Gallibacterium anatis in Poultry. Vet. Res. 2015, 46, 57. [Google Scholar] [CrossRef]
  19. Tang, B.; Bojesen, A.M. Immune Suppression Induced by Gallibacterium anatis Gtxa during Interaction with Chicken Macrophage-like HD11 Cells. Toxins 2020, 12, 536. [Google Scholar] [CrossRef]
  20. Kristensen, B.M.; Frees, D.; Bojesen, A.M. GtxA from Gallibacterium anatis, a Cytolytic RTX-Toxin with a Novel Domain Organisation. Vet. Res. 2010, 41, 25. [Google Scholar] [CrossRef]
  21. Yang, X.; Xia, Y.H.; Wang, J.-Y.; Li, Y.-T.; Chang, Y.-F.; Chang, H.-T.; Liu, H.-Y.; Chen, L.; Wang, C.-Q. The Role of GtxA during Gallibacterium anatis Infection of Primary Chicken Oviduct Epithelial Cells. Mol. Cell Probes 2020, 53, 101641. [Google Scholar] [CrossRef] [PubMed]
  22. Persson, G.; Pors, S.E.; Thøfner, I.C.N.; Bojesen, A.M. Vaccination with Outer Membrane Vesicles and the Fimbrial Protein FlfA Offers Improved Protection against Lesions Following Challenge with Gallibacterium anatis. Vet. Microbiol. 2018, 217, 104–111. [Google Scholar] [CrossRef] [PubMed]
  23. Algammal, A.M.; Hashem, M.E.A.; Alfifi, K.J.; Al-Otaibi, A.S.; Alatawy, M.; Eltarabili, R.M.; El-Ghany, W.A.A.; Hetta, H.F.; Hamouda, A.M.; Elewa, A.A.; et al. Sequence Analysis, Antibiogram Profile, Virulence and Antibiotic Resistance Genes of XDR and MDR Gallibacterium anatis Isolated from Layer Chickens in Egypt. Infect. Drug Resist. 2022, 15, 4321–4334. [Google Scholar] [CrossRef] [PubMed]
  24. Brian, V. Lubbers. CLSI VET03 Methods for Antimicrobial Broth Dilution and Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals. In Approved Guideline A Guideline for Global Application Developed Through the Clinical and Laboratory Standards Institute Consensus Process; Clinical & Laboratory Standards Institute: Malvern, PA, USA, 2020; Available online: www.clsi.org (accessed on 13 October 2024).
  25. Wang, C.; Robles, F.; Ramirez, S.; Riber, A.B.; Bojesen, A.M. Culture-Independent Identification and Quantification of Gallibacterium anatis (G. anatis) by Real-Time Quantitative PCR. Avian Pathol. 2016, 45, 538–544. [Google Scholar] [CrossRef]
  26. Kursa, O.; Tomczyk, G.; Sieczkowska, A.; Sawicka-Durkalec, A. Antibiotic Resistance of Gallibacterium anatis Biovar Haemolytica Isolates from Chickens. J. Vet. Res. 2024, 68, 93–100. [Google Scholar] [CrossRef]
  27. Bojesen, A.M.; Vazquez, M.E.; Robles, F.; Gonzalez, C.; Soriano, E.V.; Olsen, J.E.; Christensen, H. Specific Identification of Gallibacterium by a PCR Using Primers Targeting the 16S RRNA and 23S RRNA Genes. Vet. Microbiol. 2007, 123, 262–268. [Google Scholar] [CrossRef]
  28. Kursa, O.; Tomczyk, G.; Sieczkowska, A.; Sawicka-Durkalec, A. Prevalence, Identification and Antibiotic Resistance of Gallibacterium anatis Isolates from Chickens in Poland. Pathogens 2023, 12, 992. [Google Scholar] [CrossRef]
  29. El-Gazzar, M.M.; Wetzel, A.N.; Raviv, Z. The Genotyping Potential of the Mycoplasma Synoviae VlhA Gene. Avian Dis. 2012, 56, 711–719. [Google Scholar] [CrossRef]
  30. Kursa, O.; Tomczyk, G.; Sieczkowska, A.; Kostka, S.; Sawicka-Durkalec, A. Mycoplasma Gallisepticum and Mycoplasma Synoviae in Turkeys in Poland. Pathogens 2024, 13, 78. [Google Scholar] [CrossRef]
  31. Ferguson, N.M.; Hepp, D.; Sun, S.; Ikuta, N.; Levisohn, S.; Kleven, S.H.; García, M. Use of Molecular Diversity of Mycoplasma Gallisepticum by Gene-Targeted Sequencing (GTS) and Random Amplified Polymorphic DNA (RAPD) Analysis for Epidemiological Studies. Microbiology 2005, 151, 1883–1893. [Google Scholar] [CrossRef]
  32. Abdelwhab, E.M.; Lüschow, D.; Hafez, H.M. Development of Real-Time Polymerase Chain Reaction Assay for Detection of Ornithobacterium Rhinotracheale in Poultry. Avian Dis. 2013, 57, 663–666. [Google Scholar] [CrossRef] [PubMed]
  33. Kursa, O.; Tomczyk, G.; Sawicka-durkalec, A. Occurrence of Ornithobacterium Rhinotracheale in Polish Turkey Flocks. J. Vet. Res. 2022, 66, 77–84. [Google Scholar] [CrossRef] [PubMed]
  34. Yaman, S.; Sahan Yapicier, O. Gallibacterium anatis: Moleculer Detection of Tetracycline Resistance and Virulence Gene. J. Worlds Poult. Res. 2020, 10, 385–390. [Google Scholar] [CrossRef]
  35. Hess, C.; Grafl, B.; Bagheri, S.; Kaesbohrer, A.; Zloch, A.; Hess, M. Antimicrobial Resistance Profiling of Gallibacterium anatis from Layers Reveals High Number of Multiresistant Strains and Substantial Variability Even Between Isolates from the Same Organ. Microb. Drug Resist. 2020, 26, 169–177. [Google Scholar] [CrossRef]
  36. Allahghadry, T.; Ng, D.Y.K.; Dibaei, A.; Bojesen, A.M. Clonal Spread of Multi-Resistant Gallibacterium anatis Isolates among Iranian Broilers and Layers. Vet. Res. 2021, 52, 27. [Google Scholar] [CrossRef]
  37. Nassik, S.; Tallouzt, S.; Karbach, N.; Touzani, C.; Bidoudan, Y.; Aamarine, N.; Hess, C. First Report of Isolation of Gallibacterium anatis from Layer Chickens in Morocco with Decrease in Laying Performance. Avian Dis. 2019, 63, 727–730. [Google Scholar] [CrossRef]
  38. Jones, K.H.; Thornton, J.K.; Zhang, Y.; Mauel, M.J. A 5-Year Retrospective Report of Gallibacterium anatis and Pasteurella Multocida Isolates from Chickens in Mississippi. Poult. Sci. 2013, 92, 3166–3171. [Google Scholar] [CrossRef]
  39. Karwańska, M.; Wieliczko, A.; Bojesen, A.M.; Villumsen, K.R.; Krzyżewska-Dudek, E.; Woźniak-Biel, A. Isolation and Characterization of Multidrug Resistant Gallibacterium anatis Biovar Haemolytica Strains from Polish Geese and Hens. Vet. Res. 2023, 54, 67. [Google Scholar] [CrossRef]
  40. Bojesen, A.M.; Vazquez, M.E.; Bager, R.J.; Ifrah, D.; Gonzalez, C.; Aarestrup, F.M. Antimicrobial Susceptibility and Tetracycline Resistance Determinant Genotyping of Gallibacterium anatis. Vet. Microbiol. 2011, 148, 105–110. [Google Scholar] [CrossRef]
  41. Shabbir, M.Z.; Kariyawasam, S.; Pierre, T.A.; Dunn, P.A.; Wallner-Pendleton, E.A.; Lu, H. Identification, 16S RRNA–Based Characterization, and Antimicrobial Profile of Gallibacterium Isolates from Broiler and Layer Chickens. J. Vet. Diagn. Investig. 2023, 35, 13–21. [Google Scholar] [CrossRef]
  42. Elbestawy, A.R.; Ellakany, H.F.; Abd El-Hamid, H.S.; Bekheet, A.A.; Mataried, N.E.; Nasr, S.M.; Amarin, N.M. Immunology, Health, and Disease: Isolation, Characterization, and Antibiotic Sensitivity Assessment of Gallibacterium anatis Biovar Haemolytica, from Diseased Egyptian Chicken Flocks during the Years 2013 and 2015. Poult. Sci 2018, 97, 1519–1525. [Google Scholar] [CrossRef] [PubMed]
  43. Frey, J.; Kuhnert, P. RTX Toxins in Pasteurellaceae. Int. J. Med. Microbiol. 2002, 292, 149–158. [Google Scholar] [CrossRef] [PubMed]
  44. Christensen, H.; Bisgaard, M.; Bojesen, A.M.; Mutters, R.; Olsen, J.E. Genetic Relationship among Avian Isolates Classified as Pasteurella haemolytica, “Actinobacillus salpingitidis” or Pasteurella Anatis with Proposal of Gallibacterium anatis Gen. Nov., Comb. Nov. and Description of Additional Genomospecies with Gallibacterium Gen. Nov. Int. J. Syst. Evol. Microbiol. 2003, 53, 275–287. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, C.; Pors, S.E.; Olsen, R.H.; Bojesen, A.M. Transmission and Pathogenicity of Gallibacterium anatis and Escherichia Coli in Embryonated Eggs. Vet. Microbiol. 2018, 217, 76–81. [Google Scholar] [CrossRef] [PubMed]
  46. Paudel, S.; Ruhnau, D.; Wernsdorf, P.; Liebhart, D.; Hess, M.; Hess, C. Presence of Avibacterium paragallinarum and Histopathologic Lesions Corresponds with Clinical Signs in a Co-Infection Model with Gallibacterium anatis. Avian Dis. 2017, 61, 335–340. [Google Scholar] [CrossRef]
  47. Paudel, S.; Hess, M.; Hess, C. Coinfection of Avibacterium paragallinarum and Gallibacterium anatis in Specific-Pathogen-Free Chickens Complicates Clinical Signs of Infectious Coryza, Which Can Be Prevented by Vaccination. Avian Dis. 2017, 61, 55–63. [Google Scholar] [CrossRef]
  48. El-Adawy, H.; Bocklisch, H.; Neubauer, H.; Hafez, H.M.; Hotzel, H. Identification, Differentiation and Antibiotic Susceptibility of Gallibacterium Isolates from Diseased Poultry. Ir. Vet. J. 2018, 71, 5. [Google Scholar] [CrossRef]
Figure 1. Ovarian and oviduct reproductive tract tissue of infected laying hens: (a) unchanged; (b) changed (degeneration of the ovarian follicles and reduced oviduct).
Figure 1. Ovarian and oviduct reproductive tract tissue of infected laying hens: (a) unchanged; (b) changed (degeneration of the ovarian follicles and reduced oviduct).
Pathogens 13 00989 g001
Figure 2. Antibiotics, their classes, and the percentages of strains which resisted them among Gallibacterium anatis biovar haemolytica isolates from layer hen reproductive tracts. Colors distinguish antibiotic classes.
Figure 2. Antibiotics, their classes, and the percentages of strains which resisted them among Gallibacterium anatis biovar haemolytica isolates from layer hen reproductive tracts. Colors distinguish antibiotic classes.
Pathogens 13 00989 g002
Figure 3. AMR of G. anatis biovar haemolytica isolates: (a) number and percentage of isolates resistant to different antibiotics. (b) number and percentage of isolates resistant to different classes of antibiotics.
Figure 3. AMR of G. anatis biovar haemolytica isolates: (a) number and percentage of isolates resistant to different antibiotics. (b) number and percentage of isolates resistant to different classes of antibiotics.
Pathogens 13 00989 g003
Table 1. Number of isolates by origin site in the layer hen reproductive tract.
Table 1. Number of isolates by origin site in the layer hen reproductive tract.
Flock No.Age of Birds (Week)OvaryInfundibulumUterus
130101
228102
331001
431102
528001
628101
730202
827102
929001
1028002
Total7015
Table 2. AMR profiles of the G. anatis biovar haemolytica isolates.
Table 2. AMR profiles of the G. anatis biovar haemolytica isolates.
AMR ProfileNumber of Isolates
AML, ENR, TY, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, TGC, VA2
AML, ENR, TY, CAZ, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, TGC, VA1
AML, ENR, TY, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, VA3
AML, FFC, ENR, TY, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, VA1
AML, ENR, TY, TIL, AMP, CIP, E, CN, LZD, QD/SYN, TEC, TE, TGC, VA1
AML, ENR, TY, CT, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, VA1
ENR, TY, TIL, CIP, TE1
DO, FFC, ENR, TY, CT, TIL1
DO, ENR, TY, CT, TIL, QD/SYN, TEC, TE, VA1
DO, ENR, TY, CT, CAZ, TIL1
DO, AML, ENR, TY, CT, TIL, AMP, DAP, E, CN, LZD, TE, TGC, VA1
DO, AML, ENR, TY, CT, TIL, AMP, DAP, E, CN, LZD, QD/SYN, TEC, TE, VA1
DO, AML, ENR, TY, TIL, AMP, CIP, DAP, E, CN, LZD, QD/SYN, TEC, TE, VA2
Total17
AML—amoxicillin; ENR—enrofloxacin; TY—tylosin; TIL—tilmicosin; AMP—ampicillin; CIP—ciprofloxacin; DAP—daptomycin; E—erythromycin; CN—gentamycin; LZD—linezolid; QD/SYN—quinupristin/dalfopristin; TEC—teicoplanin; TE—tetracycline; TGC—tigecycline; VA—vancomycin; CAZ—ceftazidime; FFC—florfenicol; CT—colistin; DO—doxycycline.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kursa, O. Multidrug Resistance of Gallibacterium anatis Biovar Haemolytica Isolated from the Reproductive Tracts of Laying Hens. Pathogens 2024, 13, 989. https://doi.org/10.3390/pathogens13110989

AMA Style

Kursa O. Multidrug Resistance of Gallibacterium anatis Biovar Haemolytica Isolated from the Reproductive Tracts of Laying Hens. Pathogens. 2024; 13(11):989. https://doi.org/10.3390/pathogens13110989

Chicago/Turabian Style

Kursa, Olimpia. 2024. "Multidrug Resistance of Gallibacterium anatis Biovar Haemolytica Isolated from the Reproductive Tracts of Laying Hens" Pathogens 13, no. 11: 989. https://doi.org/10.3390/pathogens13110989

APA Style

Kursa, O. (2024). Multidrug Resistance of Gallibacterium anatis Biovar Haemolytica Isolated from the Reproductive Tracts of Laying Hens. Pathogens, 13(11), 989. https://doi.org/10.3390/pathogens13110989

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop